Dermatomyositis Clinical Trials Dermatomyositis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Baricitinib for Cutaneous Dermatomyositis
Condition:   Dermatomyositis Intervention:   Drug: Baricitinib Sponsor:   University of Washington Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2022 Category: Research Source Type: clinical trials